High levels of human anti-human antibodies to adalimumab in a patient not responding to adalimumab treatment

被引：32

作者：

Bartelds, G. M.

Wolbink, G. J.

Stapel, S.

Aarden, L.

Lems, W. F.

Dijkmans, B. A. C.

T Nurmohamed, M. ^{[1
]}

机构：

[1] Jan Van Breemen Inst, Dept Rheumatol, Amsterdam, Netherlands

[2] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands

[3] Sanquin Res, Amsterdam, Netherlands

来源：

关键词：

D O I：

10.1136/ard.2005.049858

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1249 / 1250

页数：4

共 6 条

[1] Drug therapy - New drugs for rheumatoid arthritis
Olsen, NJ
Stein, CM
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (21) : 2167 - 2179
[2] Rituximab treatment in patients with primary Sjogren's syndrome
Pijpe, J
van Imhoff, GW
Spijkervet, FKL
Roodenburg, JLN
Wolbink, GJ
Mansour, K
Vissink, A
Kallenberg, CGM
Bootsma, H
[J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (09): : 2740 - 2750
[3] van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.0.CO
[4] 2-K
[5] Relationship between serum trough infliximab levels, pretreatment C reactive protein levels, and clinical response to infliximab treatment in patients with rheumatoid arthritis
Wolbink, GJ
Voskuyl, AE
Lems, WF
de Groot, E
Nurmohamed, MT
Tak, PP
Dijkmans, BAC
Aarden, L
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) : 704 - 707
[6] Development of antiinfliximab antibodies and relationship to clinical response in patients with rheumatoid arthritis
Wolbink, GJ
Vis, M
Lems, W
Voskuyl, AE
de Groot, E
Nurmohamed, MT
Stapel, S
Tak, PP
Aarden, L
Dijkmans, B
[J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (03): : 711 - 715